An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 4, 2012, Pages 502-508

  You, JingJing ^a,b   Madigan, Michele C ^b,c   Rowe, Alexandra ^a,b   Sajinovic, Mila ^a,b   Russell, Pamela J ^a,b,d,e   Jackson, Paul ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Translational Research Institute   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD82 ANTIGEN; GELATINASE A; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANTIGENS, CD82; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; URINARY BLADDER NEOPLASMS;

EID: 84862992792     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.02.013     Document Type: Article

References (39)

1. Dong J.T., Rinker-Schaeffer C.W., Ichikawa T. Prostate cancer-biology of metastasis and its clinical implications. World J Urol 1996, 14:182-189.
2. Liu W.M., Zhang X.A. KAI1/CD82, a tumor metastasis suppressor. Cancer Lett 2006, 240:183-194.
3. Tonoli H., Barrett J.C. CD82 metastasis suppressor gene: A potential target for new therapeutics?. Trends Mol Med 2005, 11:563-570.
4. Bandyopadhyay S., Zhan R., Chaudhuri A., et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 2006, 12:933-938.
5. Jackson P., Kingsley E.A., Russell P.J. Inverse correlation between KAI1 mRNA levels and invasive behavior in bladder cancer cell lines. Cancer Lett 2000, 156:9-17.
6. Jee B., Jin K., Hahn J.H., et al. Metastasis-suppressor KAl1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway. Exp Mol Med 2003, 35:30-37.
7. Takaoka A., Hinoda Y., Satoh S., et al. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 1998, 16:1443-1453.
8. Yang X.H., Wei L.L., Tang C., et al. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 2001, 61:5284-5288.
9. Odintsova E., Voortman J., Gilbert E., et al. Tetraspanin CD82 regulates compartmentalization and ligand-induced dimerization of EGFR. J Cell Sci 2003, 116:4557-4566.
10. Odintsova E., Sugiura T., Berditchevski F. Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol 2000, 10:1009-1012.
11. Sridhar S.C., Miranti C.K. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases. Oncogene 2006, 25:2367-2378.
12. Lee J.H., Park S.R., Chay K.O., et al. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer. Cancer Res 2004, 64:4235-4243.
13. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006, 25:9-34.
14. Klein G., Vellenga E., Fraaije M.W., et al. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g., acute leukemia. Crit Rev Oncol Hematol 2004, 50:87-100.
15. Chambers A.F., Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997, 89:1260-1270.
16. Heslin MJ, Yan J, Johnson MR, et al. Role of matrix metalloproteinases in colorectal carcinogenesis. Proceedings of the 112th Annual Meeting of the Southern Surgical Association. Palm Beach (FL), December, 2000.
17. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463-516.
18. Chirco R., Liu X.W., Jung K.K., et al. Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 2006, 25:99-113.
19. Lambert E., Dasse E., Haye B., et al. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004, 49:187-198.
20. Raffetto J.D., Khalil R.A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008, 75:346-359.
21. Kawamura K., Kamiya N., Suyama T., et al. In situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer. J Urol 2004, 172:1480-1484.
22. Gerhards S., Jung K., Koenig F., et al. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology 2001, 57:675-679.
23. Nutt J.E., Durkan G.C., Mellon J.K., et al. Matrix metalloproteinases (MMPs) in bladder cancer: The induction of MMP9 by epidermal growth factor and its detection in urine. BJU Int 2003, 91:99-104.
24. Di Carlo A., Terracciano D., Mariano A., et al. Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors. Oncol Rep 2006, 15:1321-1326.
25. Monier F., Mollier S., Guillot M., et al. Urinary release of 72 and 92 kDa gelatinases, TIMPs, N-GAL and conventional prognostic factors in urothelial carcinomas. Eur Urol 2002, 42:356-363.
26. Jee B.K., Park K.M., Surendran S., et al. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line. Biochem Biophys Res Commun 2006, 342:655-661.
27. Russell P.J., Wass J., Lukeis R., et al. Characterization of cell-lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13. Int J Cancer 1989, 44:276-285.
28. Russell P.J., Wills E.J., Philips J., et al. In vitro studies of tumor heterogeneity in a new human bladder-carcinoma cell-line, UCRU-BL-17CL. Proc Am Assoc Cancer Res 1988, 29:23.
29. Russell P.J., Palavidis Z., Rozinova E., et al. Characterization of a new human bladder-cancer cell-line, UCRU-BL-28. J Urol 1993, 150:1038-1044.
30. Brown J.L., Russell P.J., Philips J., et al. Clonal analysis of a bladder-cancer cell line-an experimental model of tumor heterogeneity. Br J Cancer 1990, 61:369-376.
31. Vihinen P., Kahari V.M. Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets. Int J Cancer 2002, 99:157-166.
32. Grant A.J., Russell P.J., Raghavan D. Elastase activities of human bladder-cancer cell-lines derived from high-grade invasive tumors. Biochem Biophys Res Commun 1989, 162:308-315.
33. Hamasaki T., Hattori T., Kimura G., et al. Tumor progression and expression of matrix metalloproteinase-2 (MMP-2) mRNA by human urinary bladder cancer cells. Urol Res 1998, 26:371-376.
34. Chaffer C.L., Dopheide B., McCulloch D.R., et al. Up-regulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder. Clin Exp Metastasis 2005, 22:115-125.
35. Mian B.M., Dinney C.P.N., Bermejo C.E., et al. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-κB. Clin Cancer Res 2003, 9:3167-3175.
36. Eissa S., Ali-Labib R., Swellam M., et al. Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine. Eur Urol 2007, 52:1388-1397.
37. Inoue K., Slaton J.W., Kim S.J., et al. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res 2000, 60:2290-2299.
38. Guo H.M., Zucker S., Gordon M.K., et al. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 1997, 272:24-27.
39. Che Z.M., Jung T.H., Choi J.H., et al. Collagen-based co-culture for invasive study on cancer cells-fibroblasts interaction. Biochem Biophys Res Commun 2006, 346:268-275.